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CO R R E S POND EN C E
Paternal somatogonadal COL2A1 mosaicism causing
recurrence of severe type 2 collagenopathy
To the Editor:
We read with interest the report by Yamamoto et al. (2020)
describing a mild type 2 collagenopathy recurring due to maternal
somatogonadal mosaicism. We describe a similar phenomenon but in a
severe type 2 collagenopathy with paternal somatogonadal mosaicism.
Case History: A 39-year-old primigravida pregnant as a result of IVF
treatment (due to maternal severe endometriosis) was found to have a
fetus with a skeletal dysplasia at 22 weeks gestation. Scan confirmed
limbs measuring 15 weeks. Invasive prenatal investigations were
declined but noninvasive testing was negative for achondroplasia and
thanatophoric dysplasia using PCR analysis of cell free fetal DNA from
maternal plasma for the FGFR3 gene. A live born infant was delivered by
elective caesarian section at 38+6 weeks and intubated for 24 hr and a
diagnosis of hypochondrogenesis was made on radiological and genetic
assessment. Unfortunately, pediatric pathology was not available so no
postmortem was possible after final extubation at 24 hr. Examination
confirmed a small thoracic cage and short limbs (Figure 1) and limited
supine radiological examination confirmed lack of pelvic bone ossifica-
tion, 11 paired ribs with flaring of the anterior ends, extremely short long
bones with metaphyseal flaring and pointing, and no evidence of poly-
dactyly (Figure 2). WHO child growth standard measurements (de Onis,
2015) included length 36 cm (z score = −8.973), weight 2,926 g
(z score = −1.590), and head circumference 35.5 cm (z score = −0.351).
A clinical radiographic diagnosis of hypochondrogenesis was made.
Exome Sequencing analysis of a virtual panel of skeletal genes confirmed
the baby was heterozygous for the NM_001844.4(COL2A1_v001):
c.1403G > A variant resulting in the protein change NM_001844.4
(COL2A1_i001):p.(Gly468Asp), consistent with a severe type 2 col-
lagenopathy. The variant was confirmed using Sanger sequencing.
A further pregnancy ensued with a second IVF embryo success-
fully implanted. Scan at 20 weeks gestation suggested similar findings
to the first pregnancy with short limbs of around 16 weeks. Prenatal
diagnosis by amniocentesis confirmed the fetus carried the same
mutation as the first child and which was also detected in their asymp-
tomatic father. The pregnancy was terminated with no post mortem.
Further detailed clinical assessment of the father at age 45 rev-
ealed normal stature (his height 173 cm, his eldest sister 165 cm, his
younger sister 165 cm, his father 177 cm, maternal height not avail-
able) appropriate for his family and normal radiological imaging on
skeletal survey with normal eye assessment and no evidence of any
collagenopathy. Sanger sequencing analysis of his blood DNA con-
firmed 22% mosaicism; buccal cells confirmed 25% mosaicism and
cultured skin fibroblasts 20% mosaicism (Figure 3). The testing con-
firmed paternal somatogonadal mosaicism and the couple decided on
donor insemination of any further stored eggs given the high risk of
further recurrence of 50%.
This finding confirms that type 2 collagenopathies may arise from
somatogonadal mosaicism. Like the case by Yamamoto (Yamamoto
F IGURE 1 Intubated neonate showing short limbs and small
thorax and distended abdomen, with facial dysmorphism including flat
face and microretrognathia [Color figure can be viewed at
wileyonlinelibrary.com]
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et al., 2020) where there was a nonlethal dysplasia with normal mater-
nal clinical assessment, we show that severe lethal type 2 col-
lagenopathy mutations may be carried without apparent clinical
effects by a clinically normal parent. Okamoto et al. (2012) described
a case of Torrance lethal dysplasia due to a NM_001844.4
(COL2A1_v001):c.3545G > A (p.Gly1182Asp) variant (transcript infor-
mation inferred) in exon 50 of the encoded triple helical region of
COL2A1, in two siblings with similar clinical findings to our case. At
the time the parents did not consent to sampling, but it remains likely
that somatogonadal mosaicism in one parent was the cause in that
report. Although there is no clear evidence that collagenopathies have
a higher risk of parental mosaicism compared to other disorders, it
may be that the severe phenotypic effects in nonmosaic cases make
consideration of testing for parental mosaicism more likely in pheno-
typically unaffected parents. There may be a threshold effect where
high mosaicism levels may trigger symptoms or signs but a low level
does not and different tissues may vary in that threshold.
This case illustrates that parental testing should be strongly con-
sidered after the clinical presentation of mild or severe type 2 col-
lagenopathy as even in lethal cases one parent may have no apparent
clinical findings so testing may give important clinical information on
the recurrence risks and allow future reproductive options to be con-
sidered for the parents.
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F IGURE 2 Radiology showing changes suggestive of hypochondrogenesis in (a) anteroposterior (AP) chest showing platyspondyly (arrow),
small thorax, metaphyseal cupping of the anterior ribs (curved arrow), (b) AP pelvis showing absent ischiatic bones (broad arrow) and
underdeveloped lower pelvis (star), (c) AP left humerus showing metaphyseal broadening and cupping (curved double arrow), and (d) AP left femur
showing short broad tubular bones (double arrow)
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F IGURE 3 Sequencing data from the proband, mother and fetus (top), and in sampled tissues from the father A—blood, B—buccal cells, C—
fibroblasts (bottom) [Color figure can be viewed at wileyonlinelibrary.com]
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